Eleview® is a submucosal injectable composition, whose objective is to allow endoscopists with a faster and less risky excision of gastrointestinal lesions (e.g. adenomas or polyps) during endoscopy in the gastrointestinal tract. The composition is injected in the submucosal space beneath the lesion to be excised, providing a submucosal cushion of optimal height and duration, which lifts the lesion above the mucosa allowing for an easy and safe resection procedure. The submucosal cushion persists up to 45 minutes from injection, thereby giving the endoscopist sufficient time to excise the lesion while reducing the risk that the organ is perforated during the procedure.
The composition is stained with Methylene Blue which allows for a clear differentiation of the tissues and for a better visualisation of the lesion margins and of the surgical area by the endoscopist.
The FDA approved the product in September 2015. In the EU the product was approved in June 2016.
Eleview® is supplied and distributed worldwide by Medtronic with the exception of Canada, where the product is licensed to Pendopharm.